# Abbott Laboratories (ABT) P/E ratio: 39.1× today

URL: https://funkfolio.com/stock/ABT/pe-ratio

> Abbott Laboratories (ABT) P/E ratio is 39.1× today, against 33.7× at the end of fiscal 2025. Its median over 19 fiscal year-ends is 28.1×.

---

## Abbott Laboratories (ABT) P/E ratio

**P/E ratio today:** 39.1× as of Nov 18, 2026, 9:27 AM UTC

Abbott Laboratories (ABT) trades at 39.1× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 33.7×. That is 127.5% higher than the 14.8× of fiscal 2024. Figures as of 18 Nov 2026, 09:27 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **P/E ratio today:** 39.1×
- **P/E ratio, fiscal 2025:** 33.7×
- **Change on fiscal 2024:** +127.5%
- **Highest on record:** 211.4× fiscal 2017
- **Lowest on record:** 7.8× fiscal 2010
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 09:27 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Abbott Laboratories P/E ratio, in more detail

Today's figure is 16.0% above the fiscal 2025 year-end.

Across the 19 fiscal year-ends on record (2007–2025), the highest was 211.4× in fiscal 2017 and the lowest 7.8× in fiscal 2010. Today's P/E ratio is higher than at 74% of the 19 fiscal year-ends on record; their median is 28.1×.

### P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

### Abbott Laboratories P/E ratio, year by year

Abbott Laboratories (ABT) P/E ratio by fiscal year

| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
| --- | --- | --- | --- | --- | --- |
| Today | 39.1× | — | Nov 18, 2026 | $104.71 | — |
| 2025 | 33.7× | 127.5% up | Dec 31, 2025 | $125.29 | $3.72 |
| 2024 | 14.8× | 56.2% down | Dec 31, 2024 | $113.11 | $7.64 |
| 2023 | 33.8× | 20.2% up | Dec 31, 2023 | $110.07 | $3.26 |
| 2022 | 28.1× | 21.4% down | Dec 31, 2022 | $109.79 | $3.91 |
| 2021 | 35.7× | 18.4% down | Dec 31, 2021 | $140.74 | $3.94 |
| 2020 | 43.8× | 3.9% up | Dec 31, 2020 | $109.49 | $2.50 |
| 2019 | 42.2× | 22.5% down | Dec 31, 2019 | $86.86 | $2.06 |
| 2018 | 54.4× | 74.3% down | Dec 31, 2018 | $72.33 | $1.33 |
| 2017 | 211.4× | 417.3% up | Dec 31, 2017 | $57.07 | $0.27 |
| 2016 | 40.9× | 165.7% up | Dec 31, 2016 | $38.41 | $0.94 |
| 2015 | 15.4× | 49.1% down | Dec 31, 2015 | $44.91 | $2.92 |
| 2014 | 30.2× | 27.7% up | Dec 31, 2014 | $45.02 | $1.49 |
| 2013 | 23.7× | 180.1% up | Dec 31, 2013 | $38.33 | $1.62 |
| 2012 | 8.4× | 5.7% down | Dec 31, 2012 | $31.43 | $3.72 |
| 2011 | 9.0× | 15.4% up | Dec 31, 2011 | $26.98 | $3.01 |
| 2010 | 7.8× | 46.9% down | Dec 31, 2010 | $22.99 | $2.96 |
| 2009 | 14.6× | 14.5% down | Dec 31, 2009 | $25.90 | $1.77 |
| 2008 | 17.1× | 29.6% down | Dec 31, 2008 | $25.61 | $1.50 |
| 2007 | 24.3× | — | Dec 31, 2007 | $26.94 | $1.11 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

### How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

### P/E ratio at health care companies of similar size

P/E ratio of Abbott Laboratories and comparable companies

| Company | P/E ratio |
| --- | --- |
| Abbott Laboratories ABT | 39.1× |
| [Novo Nordisk NVO](https://funkfolio.com/stock/NVO/pe-ratio) | 10.3× |
| [Pfizer PFE](https://funkfolio.com/stock/PFE/pe-ratio) | 40.7× |
| [Danaher DHR](https://funkfolio.com/stock/DHR/pe-ratio) | 37.4× |
| [Intuitive Surgical ISRG](https://funkfolio.com/stock/ISRG/pe-ratio) | 52.1× |

Price over the last twelve months' earnings per share, as the market data feed reports it.

### Abbott Laboratories, figure by figure

- [Abbott Laboratories market cap](https://funkfolio.com/stock/ABT/market-cap)
- [Abbott Laboratories revenue](https://funkfolio.com/stock/ABT/revenue)
- [Abbott Laboratories earnings](https://funkfolio.com/stock/ABT/earnings)
- [Abbott Laboratories earnings per share (EPS)](https://funkfolio.com/stock/ABT/eps)
- [Abbott Laboratories P/S ratio](https://funkfolio.com/stock/ABT/ps-ratio)
- [Abbott Laboratories P/B ratio](https://funkfolio.com/stock/ABT/pb-ratio)
- [Abbott Laboratories free cash flow](https://funkfolio.com/stock/ABT/free-cash-flow)
- [Abbott Laboratories operating margin](https://funkfolio.com/stock/ABT/operating-margin)
- [Abbott Laboratories dividend](https://funkfolio.com/stock/ABT/dividend)
- [Abbott Laboratories shares outstanding](https://funkfolio.com/stock/ABT/shares-outstanding)
- [Abbott Laboratories total debt](https://funkfolio.com/stock/ABT/total-debt)
- [Abbott Laboratories cash on hand](https://funkfolio.com/stock/ABT/cash)
- [Abbott Laboratories total assets](https://funkfolio.com/stock/ABT/total-assets)
- [Abbott Laboratories return on equity (ROE)](https://funkfolio.com/stock/ABT/roe)
- [Abbott Laboratories return on invested capital (ROIC)](https://funkfolio.com/stock/ABT/roic)

[Abbott Laboratories (ABT) overview: price, valuation and scorecard](https://funkfolio.com/stock/ABT) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Abbott Laboratories P/E ratio: questions and answers

**What is Abbott Laboratories's P/E ratio?**

Abbott Laboratories (ABT) trades at 39.1× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 33.7×. That is 127.5% higher than the 14.8× of fiscal 2024.

**Is Abbott Laboratories's P/E ratio high or low compared with its own history?**

Today's P/E ratio is higher than at 74% of the 19 fiscal year-ends on record; their median is 28.1×.

**What are the highest and lowest P/E ratio figures on record for Abbott Laboratories?**

Across the 19 fiscal year-ends on record (2007–2025), the highest was 211.4× in fiscal 2017 and the lowest 7.8× in fiscal 2010.

**How is Abbott Laboratories's P/E ratio calculated?**

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Abbott Laboratories it is on record here for 19 fiscal years, 2007 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/E ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [PEG ratio: P/E adjusted for growth, and its limits](https://funkfolio.com/learn/stocks/peg-ratio)

  The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Abbott Laboratories (ABT) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ABT/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.
